Topics in Drug Testing from Quest Diagnostics
Tune in for expert insights on the latest in toxicology and drug testing.
Episodes
Tuesday Mar 17, 2020
Screening for alcohol use in pain management and primary care: it’s about time
Tuesday Mar 17, 2020
Tuesday Mar 17, 2020
The podcast will cover screening (drug testing) for alcohol use in pain management and primary care. Topics covered will include:
Understand drug and alcohol misuse and abuse
Prevalence rates of alcohol use and misuse, and alcohol use disorders
Information on alcohol use, and concomitant use with opioids and benzodiazepines
Screening guidelines
Tools and types of tests
Testing for alcohol
Breathalyzer
Advances in testing
Biomarkers
Other considerations
Quest Diagnostics approach
This episode features Quest Diagnostics Senior Medical Advisor Dr Jeff Gudin and Medical Science Liaison Dr Jack Kain.
Tuesday Dec 31, 2019
Patients with substance use disorders in medication-assisted treatment (MAT)
Tuesday Dec 31, 2019
Tuesday Dec 31, 2019
Today’s episode is on patients with substance use disorders in medication-assisted treatment (MAT). Some of the key points that will be covered include:
What is medication-assisted treatment
What are the goals of an MAT treatment program
Medications used in MAT treatment
Drug testing during MAT
Purpose of drug testing
Types of drug testing
Specimen collection
Specimen validity
Test confirmation
This episode features Quest Diagnostics Senior Medical Advisor, Dr Jeff Gudin, and Medical Science Liaison, Dr Jack Kain.
Tuesday Dec 10, 2019
Drug testing your patients for marijuana
Tuesday Dec 10, 2019
Tuesday Dec 10, 2019
Today, we will be talking about marijuana and marijuana-based products in order to:
Understand drug testing for marijuana, and why it’s important
Examine marijuana used in concert with controlled medications for pain or ADHD
Give some general recommendations for therapeutic drug monitoring for marijuana in patients with chronic pain using controlled substances
For example, at a minimum such patients should be tested before opioid therapy begins, again within 1 to 3 months, and randomly over the next 12 months, and more frequently if there are unexpected results, or there are complaints or behavior changes in the patient
The episode features Quest Diagnostics Senior Medical Advisor, Dr Jeff Gudin, and Medical Science Liaison, Dr Jack Kain. They will be discussing drug testing your patients for marijuana.